Oklahoma Senate Bill SB191

Oklahoma 2026 Regular Session

• Introduced: 2/3/25
• Refer: 2/4/25

Caption

Medical marijuana; expanding certain restrictions on certain advertising. Effective date.

Summary

SB 191 amends Oklahoma’s medical marijuana advertising law to expand restrictions on how medical marijuana businesses may market their products. The bill keeps the existing ban on deceptive, false, or misleading advertising and adds more specific prohibitions, including ads that promote overconsumption, claim curative or therapeutic effects, suggest flavored products are healthier, or use child-appealing imagery, characters, toys, flashing signs, or other designs likely to attract minors. It also bars discounts or coupons in medical marijuana advertising. The bill also adds a new signage requirement for medical marijuana commercial grower licensees. Grow operations would have to post standardized perimeter signage showing the business name, physical address, phone number, and license number in specified dimensions and format. The Oklahoma Medical Marijuana Authority would be directed to adopt rules on the signage details, and the sign would also need to comply with local county and municipal regulations. Failure to post the required signage within the stated timeframe after license renewal could result in immediate revocation of the grower license, and temporary license holders would have to comply before prelicensure inspection.

Impact

SB 191 would amend 63 O.S. 2021, Section 427.21, the statute governing medical marijuana advertising restrictions, by adding new content-based limits on advertising and a new compliance requirement for commercial grower signage. It would affect medical marijuana businesses generally, with particular operational and licensing consequences for commercial grower licensees. The bill also gives the Oklahoma Medical Marijuana Authority additional rulemaking responsibility over signage specifications and enforcement.

Sentiment

Based on the bill text and available legislative context, the measure appears to be framed as a regulatory and consumer-protection bill rather than a broad policy change. The caption and introduced language suggest support for tighter controls on medical marijuana marketing, especially to prevent misleading claims and youth-oriented advertising. There is no recorded committee transcript or vote history provided, so the public or legislative sentiment cannot be measured directly from debate, but the bill’s structure indicates an intent to strengthen oversight and compliance.

Contention

The main points of contention are likely to be the breadth of the advertising restrictions and the severity of the enforcement mechanism for grower signage. Medical marijuana businesses may view the limits on promotional content, coupons, and product marketing as burdensome or overly restrictive, while supporters would likely argue they are necessary to prevent deceptive advertising and child-directed marketing. The immediate revocation penalty for failure to post signage may also be controversial because it creates a strong licensing consequence for a compliance issue that could be seen as administrative rather than substantive.